The hypothesis is derived from cases affected by rare familial forms of AD wherein mutations in the amyloid precursor protein (APP) gene or in the presenilin-encoding (PSEN1 and PSEN2) genes, which are involved in metabolizing the APP protein, invariably lead to AD pathology. The gene discussed is APP; the disease is Alzheimer disease.